Facilitated By

San Antonio Medical Foundation

Novel accurate therapy for Multiple Sclerosis: Optimization of antisense oligonucleotides delivery and functionality in primary T cells

Texas Biomedical Research Institute


As one of the world’s leading independent biomedical research institutions, Texas Biomedical Research Institute is dedicated to advancing the health of our global community through innovative biomedical research.

Principal Investigator(s)
Ross, Corrina
Collaborating Institutions
AutoImmunity Biologic Solutions
Funded by
National Institutes of Health
Research Start Date

The research proposed here aims to optimize the delivery and functionality of a novel, biological therapy that bypasses the broad immunosuppressive mechanisms of current drugs in primary T cells, thereby addressing a major potential hurdle for this therapy.

Collaborative Project
Basic Research